key: cord-0781829-xzq3ceu4
authors: Cui, Jian; Gao, Jian; Li, Yan; Fan, Ting; Qu, Jiao; Sun, Yang; Liu, Wen; Guo, Wenjie; Xu, Qiang
title: Andrographolide sulfate inhibited NF-κB activation and alleviated pneumonia induced by poly I:C in mice
date: 2020-08-26
journal: J Pharmacol Sci
DOI: 10.1016/j.jphs.2020.08.005
sha: 0c1a4ecb085b59c4b5a89467b47a5d75483968d0
doc_id: 781829
cord_uid: xzq3ceu4

Pneumonia is a common illness that continues to be the major killer of remaining to be a significant source of morbidity and mortality in the patient population. Many microorganisms cause pneumonia, and now concern is turning to the importance of the cause the new therapies for viral pneumonia. In the current study, we report the effect of andrographolide sulfonate, a water-soluble form of andrographolide (trade name: Xi-Yan-Ping Injection), on poly I: C-induced pneumonia. Andrographolide sulfonate was administrated through intraperitoneal injection to mice with poly I: C-induced pneumonia. Recruitment of airway inflammatory cells, alteration of lung histological induced by Poly I: C were significantly ameliorated by andrographolide sulfonate. The protein levels of pro-inflammatory cytokines in bronchoalveolar fluid (BALF) and serum were reduced by andrographolide sulfonate treatment. The levels of MUC5AC and MUC5B in lung tissue were also suppressed. These results reveal that andrographolide sulfate remarkably alleviated pneumonia induced by poly I:C in mice. Moreover, andrographolide sulfonate markedly inhibited the activation of nuclear factor-κB (NF-κB). Taken together, we demonstrated that andrographolide sulfonate ameliorated poly I: C-induced pneumonia in mice, suggesting the possible use of andrographolide sulfonate for virus-induced pneumonia in clinical.

Virus pneumonia is a common illness that continues to be the major killer of people, such as severe acute respiratory syndrome (SARS-CoV), the Middle East respiratory syndrome coronavirus (MERS-CoV) and pathogenic SARS-coronavirus 2 50 (SARS-CoV-2) [1] [2] [3] [4] . Molecular diagnostic tests have greatly increased our understanding of the role of viruses in pneumonia, and findings indicate that the incidence of viral pneumonia has been underestimated 5, 6 . Despite many advances, current treatments fail to reduce lung injury and mortality 7, 8 . Further studies are still needed to better understand the cause and pathogenesis of respiratory virus infections, 55 J o u r n a l P r e -p r o o f as well as search for therapeutic strategies to improve morbidity and mortality.

Andrographolide, a diterpenoid lactone, prescribed as a treatment for upper respiratory tract infection in China, has been shown to have anti-inflammatory and anti-tumorigenic activities 9-11 . Our previous research found that andrographolide inhibited NLRP3 inflammasomes, as well as the Th1/Th17 response in colitis 10 , 60 inhibited NF-κB activation, down-regulated MAPK pathway or hampered the activation of the AIM2 inflammasome to ameliorate LPS or radiation induced lung injury 12, 13 , stabilized Bax protein to reverse resistance to 5-FU in colorectal cancer 11 .

Despite the importance of andrographolide for inflammatory diseases and that the maturation process has been elucidated, whether andrographolide contributing to 65 respiratory virus-induced pneumonia remains unknown.

Here, we reported the therapy effect of andrographolide sulfonate on mouse pneumonia induced by poly I:C and showed that andrographolide sulfonate selectively suppressed the activation of NF-κB and the proinflammation cytokines production. In addition, we found that the andrographolide sulfonate regulated 70 MUC5AC and MUC5B expression in the injured lungs. With these data, we proposed that andrographolide sulfonate may be a potential drug for the treatment of patients with severe pneumonia induced by respiratory virus. 

Poly I:C-HMW (tlrl-pic) was bought from Invivogen (San Diego, California). 85 ELISA kits for TNF-α, IL-6 and IL-1β were purchased from Dakewei (Beijing, China).

Anti-p-p65 (3033) was purchased from Cell Signaling Technology (Beverly, MA) were purchased from Cell Signaling Technology (Beverly, MA, USA). β-Actin 

To examine the histological changes, lungs from animals in each group were 

Masson's trichrome stain was used to detect the collagen deposition. Collagen volume fraction was performed by the ImageJ software as reported 15 . 

Real-time PCR was performed as reported 16 . The primer sequences used in this 125 study were as follows: 

Protein from lung tissue western blotted as reported 17 .

Immunohistochemical analysis was performed on paraffin-embedded lung tissue 150 sections (5 μm) were done as described previously 18 .

Data are expressed as mean ± SEM. ANOVA with post hoc two comparisons is used to evaluate the differences between various experimental and control groups. P values less than 0.05 were considered significant. 

and serum by induced of poly I:C 185 Next, the levels of inflammatory cytokines in BALF and serum was examined.

As expected, the proinflammation cytokines of ploy I:C group, including IL-6, TNF-α and IL-1β, were strikingly elevated in BALF and serum, while these cytokines were markedly reduced in a dose-dependent manner when treated with andrographolide sulfonate (Fig. 3A and 3B) . Moreover, the dose-response effect of andrographolide sulfonate on these genes expression in mouse lungs were determined. Consistently, the production of IL-6, TNF-α, IL-1β in total lung lysates was significantly decreased in the andrographolide sulfonate-treated animals (Fig. 3C) . Taken together, these data indicated that andrographolide sulfonate attenuated immune responses induced by poly I:C. 195 

Mucus hypersecretion is a common pathological feature seen in many acute and chronic respiratory conditions 19 . The two predominant mucins of the human airway are MUC5AC and MUC5B 20 . MUC5AC is implicated in pulmonary diseases with 200 mucus hypersecretion; and MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis 21,22 . We therefore tested whether andrographolide sulfonate could regulate the expression of mucin. We observed that, consistent with previous results, the poly I:C group exhibited increased gene and protein expression of MUC5AC and MUC5B compared to the normal group (Fig. 4A, B) . In contrast, 205 mice treated with andrographolide sulfonate showed significant decrease of MUC5AC and MUC5B expression levels following poly I:C stimulation (Fig. 4A, B) . It has been previously reported that MUC1 is a host factor known to host protects against severe pneumococcal disease 23 . Unlike the dexamethasone treatment group, there was no note difference between the andrographolide sulfonate group and the poly I: (Fig. s1 ). According to these findings, andrographolide sulfonate reduced ploy 225 I:C-induced activations of NF-κB signaling, whereas did not affect poly I:C-induced IRF3-mediated immune response.

In our study here, a mouse model of poly I:C-induced pneumonia was used to 230 evaluate the therapeutic effect of andrographolide sulfonate. According to previous studies, we characterized that andrographolide sulfonate has anti-inflammation activity 12, 26, 27 . As we expected, andrographolide sulfonate significantly inhibited the pneumonia model induced by poly I:C. In our research, we found andrographolide sulfonate significantly inhibited obviously the recruitment of airway inflammatory 235 cells and the production of pro-inflammation cytokines in the mouse pneumonia model induced by poly I:C (Fig. 2-3 ). Next this finding was confirmed by detecting the activation of NF-κB. The result showed that poly I:C stimulation increased NF-κB phosphorylation and pro-inflammation cytokines production. After treatment with andrographolide sulfonate, the NF-κB phosphorylation was much less than that of 240 poly I:C stimulation, and IL-6, TNF-α and IL-1β production induced by poly I:C were abrogated (Fig. 3-4) .

Poly I:C, a synthetic analog of dsRNA associated with viral infections, that is used to exacerbate inflammation in lung injury models [28] [29] [30] 

Viral pneumonia

Aspiration Pneumonia. NEW ENGL

Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility

Intranasal Treatment with Poly(I:C) Protects Aged Mice from Lethal Respiratory Virus Infections

Causing an Outbreak of Pneumonia

Dual respiratory 310 virus infections

Clinical review: Acute respiratory distress syndrome -clinical ventilator management and adjunct therapy

Fifty Years of Research in ARDS.Is Acute Respiratory Distress Syndrome a Preventable Disease?

Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis

Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response

Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression

Andrographolide sulfonate 325 ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-CELL

Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse

Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis

Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells

Andrographolide triggers autophagy-mediated 340 inflammation inhibition and attenuates chronic unpredictable mild stress (CUMS)-induced depressive-like behavior in mice

Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-κB pathways

Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthma

Airway Mucus Function and Dysfunction REPLY

A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis

Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-κB in a murine model of asthma

Mucin 1 protects against severe Streptococcus pneumoniae infection

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-B and EGFR pathways

Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer

Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1

Regulated Poly I:C-Induced Neutrophil Extracellular Traps and Acute Lung Injury Partly Through p38 MAP Kinase. FRONT MICROBIOL 9

Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation

The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with 385 TRIM25-Mediated RIG-I Ubiquitination

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Poly IC Triggers a Cathepsin D-and IPS-1-Dependent Pathway to Enhance Cytokine Production and Mediate 390

MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis

Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury

Siraitia grosvenorii residual extract attenuates ovalbumin-induced lung inflammation by down-regulating IL-4, IL-5, IL-13, IL-17, 400 and MUC5AC expression in mice

Ahn DW 2012. c-Ets1 inhibits the interaction of NF-κB and CREB, and downregulates IL-1β-induced MUC5AC overproduction during airway inflammation